• Certara Joins EU-ToxRisk – An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century

    Oct 12, 2015, 10:35 by Michael Croft
    PRINCETON, NJ - Oct 12, 2015 - An international consortium of 39 partner organizations will be funded by the European Commission to work on the integration of new concepts for regulatory chemical safety assessment
    Full story
  • City of Hope Turns to PFS Clinical to Mitigate Regulatory and Financial Risk with Clinical Research Coverage Analysis and Budget Standardization

    Oct 7, 2015, 14:33 by Michael Croft
    MIDDLETON, WI - Oct 7, 2015 - PFS Clinical, which offers turnkey administrative solutions that address the key pain points of establishing and running a clinical trial office, has been engaged by City of Hope to provide Coverage Analysis (CA) to ensure its clinical research trials remain compliant with complex Medicare billing regulations
    Full story
  • Rho Clinical Research Expert to Exhibit at 2015 Annual North American Cystic Fibrosis Conference

    Oct 6, 2015, 10:45 by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - Oct 6, 2015 - WHAT:  Rho, a full-service contract research organization (CRO), will exhibit at the 2015 North American Cystic Fibrosis Conference (NACFC), taking place on October 8-10, 2015 in Phoenix, Arizona
    Full story
  • Why the FDA should take more chances on riskier drugs

    Oct 6, 2015, 10:37 by Michael Croft
    Pharmalot |  An MIT study challenges the FDA to be more flexible in drug approvals, altering the odds based on the severity of the disease and availability of treatments.
    Full story
  • Sidra Medical Center Deploys NextCODE for Qatar Genome Project

    Oct 6, 2015, 07:00 by Michael Croft
    Clinical Informatics News | WuXi NextCODE today announced a long-term agreement with Sidra Medical and Research Center in Qatar. The two groups plan to co-develop comprehensive research and bioinformatics programs that will link with the Qatari national electronic medical record system.
    Full story
  • The story of AllTrials

    Oct 2, 2015, 13:49 by Michael Croft
    AllTrials |  In May, Trevor Butterworth, Director of Sense About Science USA, interviewed Ben Goldacre and Síle Lane to talk about the history of the AllTrials campaign. Here's a transcript of that interview.
    Full story
  • ERT Announces October Educational Events

    Oct 1, 2015, 11:46 by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Oct 1, 2015 - ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions today announced the educational events it is delivering during October for pharmaceutical researchers
    Full story
  • Rho Donates $28,000 to Local Public Schools through DonorsChoose.org

    Oct 1, 2015, 10:28 by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - Oct 1, 2015 - Rho, a Chapel Hill-based contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that the company will continue its support of public education in its home state through a $28,000 donation to high-poverty schools in the Research Triangle Park region of North Carolina
    Full story
  • September Clinical News and Product Briefs

    Sep 30, 2015, 13:40 by Michael Croft
    Clinical Informatics News | Clinical news and product releases from around the industry, including an electronic health monitoring partnership between a pharmacy and senior center, and an app for comparing medication prices.
    Full story
  • The Non-Negotiable Cost of Drugs

    Sep 29, 2015, 09:00 by Michael Croft
    Clinical Informatics News | Contributed Commentary | This month’s controversy surrounding Turing Pharmaceutical’s CEO Martin Shkreli’s attempt to raise the price of Daraprim by more than 5,000% was met with such outrage from payers, patients and pundits Shrkeli was forced to back off the increase. The Daraprim episode is the latest and most striking in the new “war on drugs.” The war is no longer defined as an offensive against illegal narcotics, but one against pharmaceutical companies and the increasing costs of specialty drugs.
    Full story
  • WIRB-Copernicus Group and the Prostate Cancer Clinical Trials Consortium Announce New Partnership to Improve Efficiency of Oncology Research Reviews

    Sep 29, 2015, 08:20 by Michael Croft
    PRINCETON, NJ - Sep 29, 2015 - WIRB-Copernicus Group® (WCG™), the world’s largest provider of regulatory and ethical review services and software to support clinical research, and the Prostate Cancer Clinical Trials Consortium (PCCTC), the nation’s leading multicenter clinical research organization specializing in cutting-edge prostate cancer research, today announced their new partnership to enhance the quality and efficiency of the Consortium’s research review process
    Full story
  • ERT Adds Centralized Data Surveillance for Risk-Based Monitoring to Portfolio of Respiratory Clinical Trial Solutions

    Sep 28, 2015, 08:30 by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Sep 28, 2015 - ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions today announced an expansion to its proven line of centralized respiratory solutions for global clinical trials
    Full story
  • ERT Enhances MasterScope™ for Improved Respiratory Data Collection in Clinical Trials

    Sep 28, 2015, 08:27 by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Sep 28, 2015 - ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions today announced enhancements to MasterScope, its comprehensive platform for spirometry, ECG, and home monitoring, especially designed for both standardized and centralized clinical trials
    Full story
  • Cycle Times Increasing Thanks to Start-Up Lag

    Sep 24, 2015, 12:10 by Michael Croft
    Clinical Informatics News | Despite a trend toward shorter clinical trial cycle times, recent data analysis asserts that Phase II/III cycles have actually increased.
    Full story
  • The Life of a Clinical-Trial Guinea Pig

    Sep 23, 2015, 17:09 by Michael Croft
    The Atlantic |  What it's like to earn a living as a research subject in clinical trials.
    Full story
  • Rho Experts to Speak at SESUG 2015 Conference

    Sep 22, 2015, 12:51 by Michael Croft
    CHARLOTTE, NC, UNITED STATES - Sep 22, 2015 - WHAT:  Rho, a full-service contract research organization (CRO), will highlight its expertise in SAS programming at the Southeast SAS Users Group (SESUG) 2015 Conference, being held September 27-29 in Savannah, Georgia
    Full story
  • Will IBM’s Watson Identify Patients For Your Next Trial

    Sep 16, 2015, 13:54 by Michael Croft
    Clinical Leader |  Will ICON and IBM succeed in revolutionizing clinical trial recruitment and start-up times? Both companies certainly hope so. Last week the two announced they are working together to connect patients to relevant clinical trials.
    Full story
  • Robert Califf Could Transform The FDA The Right Way

    Sep 16, 2015, 11:13 by Michael Croft
    Forbes |  People who care about making sure that medicines and medical devices are safe and effective should be cheering the nomination of Robert Califf to be the new commissioner of the Food and Drug Administration, and any senators who slow his path to the job he deserves should be accused of the basest kind of partisanship.
    Full story
  • ERT Reports Rapid Growth with ERT Insights Cloud™

    Sep 16, 2015, 07:08 by Michael Croft
    PHILADELPHIA, PA, U - Sep 16, 2015 - ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions today announced that it has experienced record growth in its ERT Insights Cloud solution – a suite of data analytics visualization, and workflow applications for use in pharmaceutical clinical development
    Full story
  • Auspherix and Domainex Expand Collaboration to Develop New Drugs that Tackle Antibiotic-Resistant Bacterial Infections

    Sep 15, 2015, 05:23 by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Sep 15, 2015 - Domainex and Auspherix today announce an expansion of their collaboration to develop new drugs to tackle the growing threat of resistance to antibiotics
    Full story
  • «
  • 261
  • 262 (current)
  • 263
  • 264
  • 265
  • 266
  • 267
  • 268
  • 269
  • 270
  • »